16 April 2021
DEMECAN again receives funding in the millions

DEMECAN, Germany’s only independent producer of medical cannabis, has closed another multi-million Euro financing round. The investment will be used for further growth as well as the expansion of the production facility, located near Dresden, into Europe’s most modern facility for the cultivation and processing of medicinal cannabis. […]

9 March 2021
DEMECAN erhält Darlehen in einstelliger Millionenhöhe von der Volksbank Mittweida eG

DEMECAN – der einzige unabhängige deutsche Produzent von medizinischem Cannabis – erhält von der Volksbank Mittweida eine Fremdkapitalfinanzierung in Millionenhöhe. Das Darlehen dient der Finanzierung des im Sommer 2020 geglückten Erwerbs der Produktionsstätte für medizinisches Cannabis. […] (only german)

3 March 2021
DEMECAN: With pioneering spirit and responsibility for patient care.

For just under four years, seriously ill patients have been able to obtain medical cannabis on prescription. Tens of thousands of patients with chronic pain, spasticity, anorexia/wasting, nausea and vomiting during chemotherapy already benefit from this additional therapy option. […]

1 February 2021
DEMECAN enters into a Medical Cannabis Supply Agreement with MediPharm Labs Australia

DEMECAN enters into a Supply-Agreement with MediPharm Labs Australia (MediPharm Labs) for the supply of multiple proprietary full-spectrum cannabis extracts. […]

10 September 2020
Cannabis Agency visits DEMECANs production facility

Dr. Constantin von der Groeben, Managing Director and co-founder of DEMECAN: “We are delighted that the cannabis agency has visited our premisesproduction facility. […]

30 July 2020
Neuer Webshop für Apotheken: DEMECAN startet Online-Vertrieb von medizinischem Cannabis

DEMECAN, der pharmazeutische Produzent und Großhändler von medizinischem Cannabis verkauft ausgewählte Produkte ab sofort online im eigenen Onlineshop. […] (only german)

19 May 2020
DEMECAN secures additional funding

DEMECAN – the German specialist for medical cannabis – has raised a […]

6 May 2020
COVID-19 restrictions impact the global supply chain: DEMECAN imports medicinal cannabis from the Netherlands to ensure supply.

The German medicinal drug market is currently experiencing exceptional circumstances due to the global COVID-19 pandemic. Supply chain […]

27 February 2020
DEMECAN signs binding supply agreement with Australia-based medical cannabis producer

DEMECAN announces the signing of a three-year supply agreement with Australian-based medical cannabis producer, Little Green Pharma, marking yet another milestone in DEMECAN’s path to guarantee a consistent supply of pharmaceutical grade cannabis to patients in Germany. The agreement is for an annual amount of at least 1,000 kg of dried flower or 48,000 units […]

24 February 2020
DEMECAN receives approval for the distribution of cannabis flowers from the Netherlands

DEMECAN is pleased to announce receipt of AmRadV approval from the German cannabis agency, marking the start of cannabis flower sales from the Netherlands. The flowers, manufactured by Bedrocan, are sold exclusively for medical purposes through pharmacies. The AmRadV regulates the sale of medicinal products treated with ionizing radiation to protect patients from bacteria, mold, […]